Fastnet Equity Share Discussion Threads

[barnes4] 30/3/2016 22:12

It all depends on the value of the company reversing in risk1

I had hoped for a premium and have to say am a little disappointed if michael walters is correct

So what is the value of Amryt?

[risk1] 30/3/2016 21:31

So what will that make re-listing share price anyone?

Thanks for info

[bigwavedave] 30/3/2016 21:21

eburne - many thanks.

[eburne1960] 30/3/2016 21:14

Announcement in the next day or two, coming back to the market second half of April as Amryt Pharma, placing @ 3p to raise £10m, and a 1 for 8 consolidation.

[bigwavedave] 30/3/2016 20:51

I'm not a subscriber badday. Not expecting you to copy and paste..but can you give the gist? ta.

[badday] 30/3/2016 20:18

It's on.

Pop to michaelwalters.com

[richpassi] 21/3/2016 18:13

why such a moderate estimation in rise Jackson, you on a down day ? lol can't wait for us to have something to chat about :)

[jacksonpollack] 21/3/2016 12:33

May the suspension be quick and the news to come sweet. Come on cathal, everything is here for massive success. Bods, money and investment opportunities. What could possibly go wrong? I await in anticipation of a 1000% rise within Q2 of 2016. PS, please.

[pottermagic2310] 18/3/2016 17:57

Looking to a positive announcement about the reverse-takeover by May and subsequent Events already muted.

[bigwavedave] 18/3/2016 12:45

Thanks. He will have something to talk about, presumably ;-)

[alphabravo321] 18/3/2016 11:34

Cathal presenting at the Proactive Investor forum on the 7th of April in London

[jacksonpollack] 16/3/2016 12:50

iPad and banana fingers are a bad combo, barnes4

[barnes4] 16/3/2016 12:35

Acquisition JP 😀

[jacksonpollack] 16/3/2016 09:02

It's only been suspended for 3 weeks and a bit, but already it seems like an age. Still, it will be worth the wait IMO. A good acquisition and two pharma companies with near term drugs in the mix too. A healthy cash balance. Plus many big names on the bods. It's gravy all the way here folks.

[risk1] 09/3/2016 14:01

We will not get the opportunity to purchase shares through an open offer or RI as this would mean more expense and delays as every I and T would need to be crossed by the ukla

Therefore suspension happened due to the leak and should not last anywhere near the several months believed by some posters

Basically once deal had been agreed 20 days later shareholders will be required to vote it through and the shares will be relisted

Maybe it will be possible to participate in placing through a broker

[papillon] 07/3/2016 12:35

I'll stop posting on here until we get the next news; that will probably be the issue of the re-admission prospectus. Until we see that I would just be wasting my time posting on here.

[pottermagic2310] 05/3/2016 12:42

Yes !!! I agree... if there's a 10 (or 100) existing for 1 approach for existing Shareholders as the reverse-takeover/merger occurs and/or during the subsequent Fund raising AND the Price is attractive, that would be very worthwhile.
It will all come down to timescales for each Event as matters unfold I guess and as ever with such things, the excitement and forward-looking Forecasts by the Markets will no doubt influence the potential Share Price and outcome for PIs sticking with the Company in the short-term right up to when acquisitions complete, assuming they proceed.

I'm feeling a lot more optimistic now I've worked thru the detail.
;-)

[risk1] 05/3/2016 08:08

I would have thought,but I could be wrong that all these things will happen simultaneously, so maybe the best time to buy more shares would be in the placing

I am hoping that the placing price will be at at a premium to the suspended price which in turn will be at a discount to the price on day one of trading in the newly formed entity??



But we will have to wait and see

[pottermagic2310] 05/3/2016 00:18

I've simply looked at a straightforward scenario with some simple numbers, as an example, to try to understand what might occur when the time comes.

Regardless of whether there ends up being nearly 2billion shares at 1p each or some other arrangement valuing the new Amryt/Fastnet merged entity at not far off what is raised in new Funding, the future value later this Year will clearly depend on the acquisitions completing AND what sort of Market there really is for the Pharma Products the new fully-formed Company produces.

116.9 new cases of Acromegaly per Million per Annum ~ 820,000+ new "Customers"/year

New Malignant NETs cases might amount to 3,500,000 per Annum

Including pre-existing cases, the one Market could be massive, the other significantly smaller but still a worthwhile venture.

The challenge would seem to be getting the Products to Market, preferably inside 2 years and challenging existing Treatments to become the Market Leader.

I've concluded now that buying in post reverse-takeover/merger and post Fund raising, ahead of acquisitions might be the best opportunity... is that a fair Bet ?

[risk1] 04/3/2016 21:48

Sorry potter I think on reflection I have been too harsh

Suggest you do a little research over the weekend

[soul limbo] 04/3/2016 20:56

' has signed conditional deals to buy two companies - Som Pharmaceuticals and Birken - which will complete if the reverse takeover goes ahead.

Amryt would then have a product, approved by the European regulator, which will be developed as a treatment for epidermolysis bullosa (EB), a genetic skin disease that causes painful blisters to form as a result of the slightest friction. Going public will enable the company to scale more quickly.'

'Other products for treating other rare diseases are in the pipeline'

[risk1] 04/3/2016 20:54

Oh for goodness sake where the heck have you come from

You are not for real imo

[soul limbo] 04/3/2016 20:54

Amryt will be acquiring two operating companies.

Read the newspaper article the day before the share was suspended.